Arcellx to Participate at the Canaccord Genuity 2023 Horizons in Oncology Virtual Conference

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

Related Keywords

Canaccord Genuity ,Andrea Cohen ,Myesha Lacy ,Arcellx Inc ,Exchange Commission ,Drug Administration ,Linkedin ,Prnewswire Arcellx Inc ,Nasdaq ,Securities Exchange ,Sam Brown Inc ,Oncology Virtual Conference ,Fast Track ,Orphan Drug ,Regenerative Medicine Advanced Therapy ,Securities Act ,Securities Exchange Act ,Annual Report ,Sam Brown ,Arcellx ,Nc ,